Managing multiple myeloma in a COVID-19 world
Managing multiple myeloma in a COVID-19 world
ESMO 2020 renal roundup
Exon 20 insertions in NSCLC - ESMO 2020
ESMO 2020: Lung cancer latest
Highlights from ESMO 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients
Breast cancer roundup from ESMO 2020
OncoAlert and ecancer weekly roundup for September 14-19, 2020
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer